Ticker
DMACCompany Name
DIAMEDICA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 269.82M | $ 506K | $ -11K | $ 0 | -0.18% |
3/31/2025 | $ 170.68M | $ 12.1M | $ -11K | $ 0 | -7.08% |
12/31/2024 | $ 256.71M | $ 12M | $ -9K | $ 0 | -4.67% |
9/30/2024 | $ 182.16M | $ 11.88M | $ -7K | $ 0 | -6.52% |
6/30/2024 | $ 138.93M | $ 11.75M | $ -6K | $ 0 | -8.45% |
3/31/2024 | $ 131.73M | $ 36.85M | $ -6K | $ 0 | -27.97% |
12/31/2023 | $ 107.04M | $ 36.85M | $ -6K | $ 0 | -34.42% |
9/30/2023 | $ 88.81M | $ 36.85M | $ -6K | $ 0 | -41.48% |
6/30/2023 | $ 107.78M | $ 36.85M | $ -6K | $ 0 | -34.19% |
3/31/2023 | $ 53.54M | $ 0 | $ -6K | $ 0 | 0.01% |
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for DIAMEDICA THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 28.89M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -5K ]) / Market Cap [ $ 85.82M ]
(=) Shareholder Yield [ -33.65% ]
Minimum
Jun 30, 2022
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.49K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |